[{"indications": "Indications\u00a0treatment of mild ulcerative colitis and maintenance of remission", "name": "OLSALAZINE SODIUM", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.5 Chronic bowel disorders", "1.5.1 Aminosalicylates", "OLSALAZINE SODIUM"], "cautions": "Cautions\u00a0\n(From 1.5.1 Aminosalicylates: British National Formulary)\nCautions\u00a0Renal function should be monitored before starting an oral aminosalicylate, at 3 months of treatment, and then annually during treatment (more frequently in renal impairment). Blood disorders can occur with aminosalicylates (see recommendation below).; interactions: Appendix 1 (aminosalicylates)Blood disorders\u00a0See %s\n(From 1.5.1 Aminosalicylates: British National Formulary)\nBlood disordersPatients receiving aminosalicylates should be advised to report any unexplained bleeding, bruising, purpura, sore throat, fever or malaise that occurs during treatment. A blood count should be performed and the drug stopped immediately if there is suspicion of a blood dyscrasia.", "side-effects": "Side-effects\u00a0see notes above; watery diarrhoea common; also\r\nreported, tachycardia, palpitation, pyrexia, blurred vision, and photosensitivity", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2173.htm", "doses": ["adult and child over 12 years, acute attack, 1\u00a0g daily in divided\r\ndoses after meals increased if necessary over 1 week to max. 3\u00a0g daily\r\n(max. single dose 1\u00a0g); maintenance, 500\u00a0mg twice daily after meals", "child under 12 years see BNF for Children"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid unless potential benefit\r\noutweighs risk"}]